U.S., EU Companies ‘Misinformed’ on Chinese Suppliers, Expert Says

U.S. and European pharma companies “are misinformed about the identity of manufacturers involved in all or part of the supply chain of 39 percent of drug substances they purchase from China,” an industry expert says.
Drug GMP Report